Company intelligence / Profile preview

Fujian Huitianhuake Biotech

Fuzhou, Fujian, China

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Fujian Huitian Bio-Pharma maintains a broad commercial portfolio including 80+ drug specifications and seven dosage forms, with at least one Class I national new drug and several exclusive Chinese medicine formulas. Its main products cover both Western small-molecule API and Chinese traditional medicine.

Therapeutic areas: Infectious DiseasesOther
Modalities: Small moleculeBiologicTraditional Chinese medicine
Industry: Biotech

Beyond the preview

Go deeper on Fujian Huitianhuake Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fujian Huitianhuake Biotech.

Explore the full profile